Literature DB >> 21251309

Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: implication in Morquio A disease.

Souhir Khedhiri1, Latifa Chkioua, Salima Ferchichi, Abdelhedi Miled, Sandrine Laradi.   

Abstract

UNLABELLED: Mucopolysaccharidosis type IVA or Morquio A syndrome is characterized by the lack of N-acetylgalactosamine-6-sulfate-sulfatase and the accumulation of keratan sulfate and chondroitin-6-sulfate in the lysosomes. At least, 148 mutations and 16 polymorphisms were identified in the GALNS gene.The aim of this study was the screening of polymorphisms within 7 patients recruited from many regions of Tunisia in order to determine the haplotypes and their association with the mutations previously reported. PATIENTS AND METHODS: We have used the PCR sequencing to analyse the different haplotypes and to identify the polymorphisms within 7 affected MPS IVA patients.
RESULTS: Nine GALNS polymorphisms were detected in the 7 studied patients. Five of these polymorphisms are within the GALNS gene exons. Six polymorphisms have been previously described and used for linkage analysis in MPS IVA patients and determination of haplotypes. We have identified two novel heterozygous polymorphisms in intron 13 and intron 3
CONCLUSION: Polymorphisms may be useful for carrier detection and prenatal diagnosis in informative families whose specific mutations have not been identified. The determination of haplotypes can also determine the origin of some mutations in a population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21251309      PMCID: PMC3034659          DOI: 10.1186/1746-1596-6-11

Source DB:  PubMed          Journal:  Diagn Pathol        ISSN: 1746-1596            Impact factor:   2.644


  14 in total

1.  Consanguinity: implications for practice, research, and policy.

Authors:  Ahmad S Teebi; Hatem I El-Shanti
Journal:  Lancet       Date:  2006-03-25       Impact factor: 79.321

2.  Mucopolysaccharidosis type IV: N-acetylgalactosamine-6-sulfatase mutations in Tunisian patients.

Authors:  S Laradi; T Tukel; S Khediri; J Shabbeer; M Erazo; L Chkioua; M Chaabouni; S Ferchichi; A Miled; R J Desnick
Journal:  Mol Genet Metab       Date:  2006-03       Impact factor: 4.797

3.  Identification of 31 novel mutations in the N-acetylgalactosamine-6-sulfatase gene reveals excessive allelic heterogeneity among patients with Morquio A syndrome.

Authors:  S Bunge; W J Kleijer; A Tylki-Szymanska; C Steglich; M Beck; S Tomatsu; S Fukuda; B J Poorthuis; B Czartoryska; T Orii; A Gal
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

4.  Polymerase chain reaction detection of two novel human N-acetylgalactosamine-6-sulfate sulfatase gene polymorphisms by single-strand conformation polymorphism analysis or by StyI and StuI cleavages.

Authors:  S Tomatsu; S Fukuda; A Uchiyama; T Hori; Y Nakashima; K Sukegawa; N Kondo; Y Suzuki; N Shimozawa; T Orii
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

5.  A novel splice site mutation in intron 1 of the GALNS gene in a Japanese patient with mucopolysaccharidosis IVA.

Authors:  S Tomatsu; S Fukuda; T Ogawa; Z Kato; K Isogai; N Kondo; Y Suzuki; N Shimozawa; K Sukegawa; T Orii
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

6.  XhoI and SphI RFLPs in the GALNS gene.

Authors:  S Tomatsu; S Fukuda; H Iwata; T Ogawa; K Sukegawa; T Orii
Journal:  Hum Mol Genet       Date:  1994-07       Impact factor: 6.150

7.  Fifteen polymorphisms in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene: diagnostic implications in Morquio disease.

Authors:  S Tomatsu; S Fukuda; A Cooper; J E Wraith; A Yamagishi; Z Kato; N Yamada; K Isogai; K Sukegawa; Y Suzuki; N Shimozawa; N Kondo; T Orii
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

8.  Mucopolysaccharidosis IVA: a comparative study of polymorphic DNA haplotypes in the Caucasian and Japanese populations.

Authors:  G M Rezvi; S Tomatsu; S Fukuda; A Yamagishi; A Cooper; J E Wraith; H Iwata; Z Kato; N Yamada; K Sukegawa; N Shimozawa; Y Suzuki; N Kondo; T Orii
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

9.  Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia.

Authors:  S Khedhiri; L Chkioua; H Bouzidi; A Dandana; H Ben Turkia; A Miled; S Laradi
Journal:  Pathol Biol (Paris)       Date:  2008-06-26

10.  Mucopolysaccharidosis IVA: identification of a common missense mutation I113F in the N-Acetylgalactosamine-6-sulfate sulfatase gene.

Authors:  S Tomatsu; S Fukuda; A Cooper; J E Wraith; G M Rezvi; A Yamagishi; N Yamada; Z Kato; K Isogai; K Sukegawa
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

View more
  4 in total

1.  Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients.

Authors:  Latifa Chkioua; Souhir Khedhiri; Hadhami Ben Turkia; Rémy Tcheng; Roseline Froissart; Henda Chahed; Salima Ferchichi; Marie Françoise Ben Dridi; Christine Vianey-Saban; Sandrine Laradi; Abdelhedi Miled
Journal:  Diagn Pathol       Date:  2011-06-03       Impact factor: 2.644

2.  Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II.

Authors:  Latifa Chkioua; Souhir Khedhiri; Salima Ferchichi; Rémy Tcheng; Henda Chahed; Roseline Froissart; Christine Vianey-Saban; Sandrine Laradi; Abdelhedi Miled
Journal:  Diagn Pathol       Date:  2011-05-23       Impact factor: 2.644

3.  Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms.

Authors:  Latifa Chkioua; Souhir Khedhiri; Asma Kassab; Amina Bibi; Salima Ferchichi; Roseline Froissart; Christine Vianey-Saban; Sandrine Laradi; Abdelhedi Miled
Journal:  Diagn Pathol       Date:  2011-04-26       Impact factor: 2.644

4.  Clinical and molecular characteristics of colombian patients with mucopolysaccharidosis IVA, and description of a new galns gene mutation.

Authors:  Lina Johanna Moreno Giraldo; Ángela María Escudero Rodríguez; Adalberto Sánchez Gómez; José María Satizabal Soto
Journal:  Mol Genet Metab Rep       Date:  2018-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.